MELISSA SYLVIA: Open Payments
NPI 1932752516 · TAUNTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 23 payments from 15 companies in 2025. Trend: 2023 $316 · 2024 $628 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $85 |
| Incyte Corporation | 3 | $75 |
| Agios Pharmaceuticals, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Janssen Biotech, Inc. | 2 | $57 |
| SOBI, INC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: SARCLISA, JAKAFI, PYRUKYND, Vonjo, SCEMBLIX, RYBREVANT, LIBTAYO, DARZALEX.
Industry payments across MA — which companies pay providers there.
